Log in

ASX:DNADonaco International Stock Price, Forecast & News

0.00 (0.00 %)
(As of 05/12/2020)
Today's Range
Now: A$0.04
50-Day Range
MA: A$0.04
52-Week Range
Now: A$0.04
Volume657,200 shs
Average Volume1.03 million shs
Market Capitalization$30.47 million
P/E RatioN/A
Dividend Yield2.86%
Donaco International Limited engages in the leisure and hospitality businesses in the Asia Pacific region. It operates Star Vegas Resort & Club, a casino and hotel complex comprising approximately 100 gaming tables, 1500 slot machines, and 385 hotel rooms in Poipet, Cambodia on the border with Thailand; and Aristo International Hotel, a boutique casino comprising 400 hotel rooms in northern Vietnam, on the border with Yunnan Province, China. The company was founded in 2002 and is based in Sydney, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.77 out of 5 stars

Industry, Sector and Symbol

Industry Resorts & Casinos



Sales & Book Value

Annual Sales$87.47 million
Cash FlowA$0.03 per share
Book ValueA$0.24 per share



Market Cap$30.47 million
Next Earnings DateN/A
OptionableNot Optionable

Receive DNA News and Ratings via Email

Sign-up to receive the latest news and ratings for DNA and its competitors with MarketBeat's FREE daily newsletter.

Donaco International (ASX:DNA) Frequently Asked Questions

How has Donaco International's stock been impacted by COVID-19 (Coronavirus)?

Donaco International's stock was trading at A$0.06 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, DNA stock has decreased by 42.2% and is now trading at A$0.04. View which stocks have been most impacted by Coronavirus.

How were Donaco International's earnings last quarter?

Donaco International Ltd (ASX:DNA) posted its quarterly earnings data on Thursday, February, 28th. The company reported ($0.05) earnings per share for the quarter. View Donaco International's earnings history.

Has Donaco International been receiving favorable news coverage?

Press coverage about DNA stock has trended negative recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Donaco International earned a news impact score of -2.3 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about Donaco International.

Who are some of Donaco International's key competitors?

Who are Donaco International's key executives?

Donaco International's management team includes the following people:
  • Mr. Keong Hoe Lim, Interim MD, CEO & Director
  • Mr. Kwong Yang Chong CPA, Chief Financial Officer
  • Mr. Benedict Paul Reichel BA, LLB (Hons), LLM (Hons), Group Gen. Counsel, Company Sec. & Exec. Director
  • Mr. Eng Hoe Tan, Chief Operating Officer (Age 50)
  • Mr. Ang Teck Foo, Gen. Director

What is Donaco International's stock symbol?

Donaco International trades on the ASX under the ticker symbol "DNA."

What is Donaco International's stock price today?

One share of DNA stock can currently be purchased for approximately A$0.04.

How big of a company is Donaco International?

Donaco International has a market capitalization of $30.47 million and generates $87.47 million in revenue each year.

What is Donaco International's official website?

The official website for Donaco International is www.donacointernational.com.

How can I contact Donaco International?

Donaco International's mailing address is L 18 420 George St, SYDNEY, NSW 2000, Australia. The company can be reached via phone at +61-2-91062149.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.